Atopic Dermatitis Skincare and Impact on Quality of Life for Patients With Skin of Color

    La Roche-Posay
  • Publication date: March 2024
  • Updated date: July 2026
  • Reading time: 5 min

ABSTRACT



Atopic Dermatitis (AD) epidemiologic studies report a higher incidence and prevalence among populations with skin of color (SOC). Additionally, differences in AD underlying gene mutations and skin morphology are observed to lead to frequent and prominent xerosis, pruritus, and pigmentary sequelae in patients of color. However, populations with SOC are underrepresented in dermatology clinical trials, including AD. This article reviews the nuances in AD epidemiology, clinical presentation, and impact on quality-of-life among populations with SOC, plus highlight the role of skincare in AD management.